Back to Search Start Over

Alpha-synuclein repeat variants and survival in Parkinson's disease.

Authors :
Chung SJ
Biernacka JM
Armasu SM
Anderson K
Frigerio R
Aasly JO
Annesi G
Bentivoglio AR
Brighina L
Chartier-Harlin MC
Goldwurm S
Hadjigeorgiou G
Jasinska-Myga B
Jeon BS
Kim YJ
Krüger R
Lesage S
Markopoulou K
Mellick G
Morrison KE
Puschmann A
Tan EK
Crosiers D
Theuns J
Van Broeckhoven C
Wirdefeldt K
Wszolek ZK
Elbaz A
Maraganore DM
Source :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2014 Jul; Vol. 29 (8), pp. 1053-7. Date of Electronic Publication: 2014 Feb 27.
Publication Year :
2014

Abstract

Objectives: To determine whether α-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD).<br />Methods: Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow-up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival.<br />Results: Twenty-one sites contributed data for 6,154 cases. There was no significant association between α-synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01-1.10; P value = 0.01).<br />Conclusions: In our large consortium study, α-synuclein REP1 genotypes were not associated with survival in PD. Further studies of α-synuclein's role in disease progression and long-term outcomes are needed.<br /> (© 2014 International Parkinson and Movement Disorder Society.)

Details

Language :
English
ISSN :
1531-8257
Volume :
29
Issue :
8
Database :
MEDLINE
Journal :
Movement disorders : official journal of the Movement Disorder Society
Publication Type :
Academic Journal
Accession number :
24578302
Full Text :
https://doi.org/10.1002/mds.25841